Skip to main content
Byetta 250 ug/mL injection by AstraZeneca Pharmaceuticals LP
Byetta, 250 ug/mL, injection Drug class: GLP-1 Receptor Agonist. Available on prescription only. Listed by AstraZeneca Pharmaceuticals LP.
Prescription only

Byetta

exenatide

Listed by AstraZeneca Pharmaceuticals LP

Strength
250 ug/mL
Form
Injection
Route
Subcutaneous
Class
GLP-1 Receptor Agonist

What it contains

  • Exenatide 250 ug/mL

FDA record

Dosage form Injection
Route Subcutaneous
Drug class GLP-1 Receptor Agonist
Approval route NDA — original brand approval
NDC code 0310-6512
FDA application NDA021773
RxNorm concept 847910
Package sizes listed 1
Marketed since December 2014

Other products containing Exenatide

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Byetta

exenatide

Strength
250 ug/mL
Form
Injection
Class
GLP-1 Receptor Agonist
Rx only

AstraZeneca Pharmaceuticals LP

Not stocked by us — reference only

Exenatide

Strength
250 ug/mL
Form
Injection
Class
GLP-1 Receptor Agonist
Rx only Generic

Amneal Pharmaceuticals LLC

Not stocked by us — reference only

Exenatide

Strength
250 ug/mL
Form
Injection
Class
GLP-1 Receptor Agonist
Rx only Generic

Amneal Pharmaceuticals LLC

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.